A phase I/II dose-escalation multi-center study to evaluate the safety of infusion of natural killer cells or memory T cells as adoptive therapy in coronavirus pneumonia and/or lymphopenia: RELEASE study protocol.
Saved in:
| Title: | A phase I/II dose-escalation multi-center study to evaluate the safety of infusion of natural killer cells or memory T cells as adoptive therapy in coronavirus pneumonia and/or lymphopenia: RELEASE study protocol. |
|---|---|
| Authors: | García-García, I.1 (AUTHOR), Guerra-García, P.1,2,3 (AUTHOR), Ferreras, C.3 (AUTHOR), Borobia, A. M.1,3,4 (AUTHOR), Carcas, A. J.1,3,4 (AUTHOR), Queiruga-Parada, J.1 (AUTHOR), Vicario, J. L.5 (AUTHOR), Mirones, I.2 (AUTHOR), Solano, C.6 (AUTHOR), Eguizabal, C.7,8 (AUTHOR), Soria, B.9,10,11 (AUTHOR), Pérez-Martínez, A.2,3,4 (AUTHOR) aperezmartinez@salud.madrid.org |
| Source: | Trials. 10/2/2021, Vol. 22 Issue 1, p1-12. 12p. 1 Diagram, 3 Charts. |
| Database: | Academic Search Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
Be the first to leave a comment!
